Company name
2022Founder
Evan Feinberg leads Genesis Therapeutics, which develops deep-learning and foundation-model methods for drug discovery. He previously developed machine-learning methods for molecular property prediction in Vijay Pande’s Stanford lab and consulted on deep learning for Merck; his Stanford research included PotentialNet, a neural-network architecture for chemistry.
Co-Founder and CEO
Co-Founder and CEO at Genesis Therapeutics.
Deep Learning Consultant
Computational Biophysics Intern
Research Fellow, SURP
Founder and CEO
PhD, Biophysics (2013–2018)
BS, Applied Physics (2009–2013)